Andrew Matzkin

Andrew joined Health Advances in 2009. He co-leads the firm’s Digital Health and Health IT Practice.

Andrew applies his deep expertise in commercial strategy and product development strategy in healthcare to a wide range of digital technology areas, including digital therapeutics, connected devices and diagnostics, wearables, remote patient monitoring, medication adherence, advanced analytics, clinical decision support, precision medicine software, real world evidence, and data monetization.

Andrew works closely with clients in digital health, tech, and the life sciences, as well as with investors in these areas, to help maximize the value of these exciting and rapidly evolving technologies.

Additionally, Andrew also works regularly with clients in private equity and medtech on a range of non-digital strategy questions, leveraging his extensive experience across many categories of medical equipment, consumables, and services in acute, ambulatory, and home settings.

Serving as a Strategic Advisor to the Digital Therapeutics Alliance, Andrew works closely with leading companies in digital therapeutics and biopharma to help pave the way for acceptance and adoption of digital therapeutics.

Work Experience

Prior to Health Advances, Andrew was a Consultant at Bain & Company and Axia Limited, where he focused on supply chain strategy, operational efficiency, cost reduction, and merger integration. He also worked at Novartis in the global cardiovascular-metabolic franchise.

Education

Andrew earned his BA degree in Political Science, magna cum laude and Phi Beta Kappa, from Yale University and an MBA from Harvard Business School, where he was honored as a Baker Scholar.